Polycystic ovary syndrome, an enigmatic syndrome begging for a name change


Like Comment

Volume 108, Issue 5, Pages 748–749


Zev Rosenwaks, M.D.


More than any other reproductive endocrine disorder, polycystic ovary syndrome (PCOS) has engendered great interest, fascination, passion and controversy. This heterogeneous and enigmatic condition has been the subject of multiple expert consensus conferences, all aiming to unify and/or clarify the PCOS spectrum of clinical and biochemical presentations.

Read the full text here.

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.


Go to the profile of Hazout Andre
over 3 years ago

Despite several consensus conferences, there is indeed no ideal name for a syndrome that has several variants: often without cyst before stimulation, with or without hyperandrogenism, with or without metabolic syndrome ..... What is grouped under the generic term polycystic ovaries is actually a state of polyfollicular ovaries where insulin resistance and / or hyperandrogenism and/or metabolic disturbance may complicate the definition and prognosis of different situations that do not fall under ART
I therefore gladly subscribe to the Zev project because only a better definition of these different clinical cases will lead to better management with a clear reduction in known risks.